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Epidemiological studies suggest that prenatal exposure to different types of viral or
bacterial infections may be associated with similar outcomes; i.e., an increased risk of
mental illness disorders in the offspring. Infections arising from various causes have
similar debilitating effects in later life, suggesting that the exact pathogen may not be
the critical factor in determining the neurological and cognitive outcome in the offspring.
Instead, it is thought that response of the innate immune system, specifically the
increased production of inflammatory cytokines, may be the critical mediator in altering
fetal brain development pre-disposing the offspring to mental illness disorders later in
life. Inflammatory cytokines are essential for normal brain development. Factors such as
the site of cytokine production, a change in balance between anti- and pro- inflammatory
cytokines, placental transfer of cytokines, the effects of cytokines on glial cells, and the
effects of glucocorticoids are important when evaluating the impact of maternal infection
on fetal brain development. Although it is clear that cytokines are altered in the fetal brain
following maternal infection, further evidence is required to determine if cytokines are
the critical factor that alters the trajectory of brain development, subsequently leading to
postnatal behavioral and neurological abnormalities.
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INTRODUCTION
Genetic background and environmental factors can predispose
an individual to neuropsychiatric disorders, although the preva-
lence of conditions such as schizophrenia and autism cannot
be accounted for by these factors alone (Williams et al., 2006;
Tandon et al., 2008). The exact aetiology and pathophysiology of
schizophrenia and autism remain unknown, but immunological
factors are thought to play a role. Evidence of immune abnormal-
ities including dysregulation of immune-related genes, changes
in the activation of glial cells, and expression of inflammatory
mediators have been observed in the brains of patients with these
disorders (Pardo et al., 2005; Vargas et al., 2005; Arion et al.,
2007; Chez et al., 2007; Morgan et al., 2010). It has therefore
been suggested that immune-induced inflammation is a candi-
date event in creating a vulnerability in the brain that predisposes
an individual, perhaps already at risk due to genetic and environ-
mental influences, to develop the neuropathology and behavioral
and cognitive impairments observed in major disorders such as
schizophrenia and autism (Rehn and Rees, 2005; Meyer et al.,
2011). Due to the debilitating nature of these conditions, their
relatively high incidence in the community, and the great public
health burden of these disorders, it is important to identify the
causative factors in order to develop interventions and treatments
for them, which might then become therapies that ameliorate or
correct these disorders.
NEURODEVELOPMENTAL BASIS OF MENTAL ILLNESS
In the 1960s and 1970s, several studies showed an increase in
the incidence of mental retardation in children born to mothers
who were pregnant during the 1964 rubella epidemic (Stern
et al., 1969; Chess, 1971; Chess et al., 1978). More recent studies,
based on serological testing and clinical examination to deter-
mine rubella exposure during pregnancy have provided further
convincing support for association between maternal infection
during pregnancy and the development of mental retardation in
the offspring (Brown et al., 2000a, 2001). The “1968 Hong Kong”
influenza epidemic is another example of an exposure that, for
women pregnant at the time, increased the risk of their children
developing mental illness in later life—schizophrenia especially—
with second trimester exposure being of particular significance
(Mednick et al., 1988; Kendell and Kemp, 1989; Machón et al.,
2002). In contrast, other studies concluded that prenatal expo-
sure to influenza epidemics was unrelated to the development of
mental illness in postnatal life (Crow and Done, 1992; Selten and
Slaets, 1994; Morgan et al., 1997; Selten et al., 2009), but many
of these were conducted retrospectively with influenza exposure
based on timing of epidemics and a reliance on mothers to recall
infection exposure after the pregnancy. These limitations weaken
the validity of these studies and may be the reason an association
between maternal influenza and an increased incidence of mental
illness disorders was not found. In contrast, a study with convinc-
ing serological evidence to determine prenatal influenza exposure
did find that influenza contracted during pregnancy increased the
risk of schizophrenia in later life (Brown et al., 2004a).
Exposure to other infections in pregnancy have also been
linked with the development of mental illness disorders, with an
increased risk in children born to mothers where herpes simplex
virus type 2 (Buka et al., 2001b) and toxoplasmosis (Brown et al.,
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2005; Mortensen et al., 2007) were detected during pregnancy.
Epidemiological studies have also found that prenatal exposure
to poliovirus (Fuller Torrey et al., 1988; Suvisaari et al., 1999),
measles (Fuller Torrey et al., 1988), varicella-zoster (Fuller Torrey
et al., 1988) and maternal genital and reproductive infections
(Babulas et al., 2006) are all associated with an increased incidence
of mental illness in the child in later life.
That similar outcomes can arise from quite varied infection in
pregnancy suggests that responses in the maternal, placental or
fetal compartments common to this type of immune challenge
can result in altered development of the fetal brain. Importantly,
whatever it is in the intra-uterine environment, or in placental
and fetal tissues that is affected by maternal infection, they appear
to induce long-lasting changes that, despite the much-discussed
“plasticity” of the brain throughout life, nevertheless lead to a
predisposition for the development of mental disorders in post-
natal life, an outcome with debilitating consequences not only for
the individual concerned, but also for their immediate family and
society at a large.
ARE CYTOKINES THE CRITICAL MEDIATOR?
The numerous epidemiological studies showing an association
between prenatal viral infections and an increased risk of men-
tal illness in later life do not identify the critical factors in the
disruption of fetal brain development. It is possible that fac-
tors common to the maternal immune system, and induced by
any pathogen, viral or bacterial, may be affecting fetal brain
development and leading to these postnatal behavioral disorders.
Research has suggested that maternal induction or a change in
the balance of pro- and anti-inflammatory cytokines may be a
key mechanism involved in altering the normal course of fetal
brain development (Gilmore and Jarskog, 1997; Ashdown et al.,
2006; Meyer et al., 2009; Watanabe et al., 2010). It is important to
note that other possible mechanisms by which a maternal infec-
tion could disrupt fetal development, include maternal and fetal
malnutrition, hyperthermia, fetal growth restriction, and obstet-
ric complications such as preeclampsia and preterm birth. As
these factors do not consistently arise and are not common to
all maternal infections, they are not discussed in depth in this
review.
To eliminate microorganisms, such as bacteria and viruses, the
innate immune system triggers the activation of Toll-like recep-
tors (TLRs) (Takeda and Akira, 2005; Takeuchi and Akira, 2007).
TLR activation triggers a cascade of signal transduction events
causing the transcription of genes encoding cytokines, interfer-
ons and other immunological mediators (Takeda and Akira, 2005;
Takeuchi and Akira, 2007). In the adult, cytokines, a family of
soluble polypeptides, have been shown to be activated by these
actions of the innate immune system, in response to both bac-
terial and viral infections (Imanishi, 2000; Borish and Steinke,
2003). It is thought that inflammatory cytokines not only play
a key role in the resolution of disease, but in contrast, can also
contribute to the development of inflammation (Hanada and
Yoshimura, 2002).
Serological evidence further supports the concept that inflam-
matory mediators, produced in response to an infectious ill-
ness, may be involved in the development of mental disorders
in postnatal life. Brown et al. (2004b) identified higher lev-
els of serum interleukin (IL)-8 during pregnancy in mothers,
particularly during the second trimester, whose child eventu-
ally developed schizophrenia. Increased serum levels of tumor
necrosis factor (TNF)-α at birth have also been found in moth-
ers whose child subsequently developed schizophrenia or other
psychotic disorders (Buka et al., 2001a). Abnormalities in the
constitutive expression of immunological factors also appear to
be involved, in that chronically increased levels of IL-1β, IL-
6, IL-8 and TNF-α are positively associated with the severity
of the schizophrenia or autism that eventually develops (Maes
et al., 2002; Chez et al., 2007; Potvin et al., 2008; Ashwood et al.,
2011).
THE ROLE OF CYTOKINES IN NORMAL BRAIN
DEVELOPMENT
Numerous studies have identified changes in cytokine lev-
els throughout normal human pregnancy in maternal serum
and amniotic fluid (Austgulen et al., 1994; Kruse et al., 2000;
Heikkinen et al., 2001; Chow et al., 2008; Curry et al., 2008), but
fewer have investigated cytokine levels in the human fetal brain
through development, most likely due to difficulties in obtain-
ing samples. A study conducted more than a decade ago, used
in situ hybridization to find cytokine and chemokine expression
in forebrain cells of human fetuses from 5 weeks of gestation
(Mousa et al., 1999), suggesting a role for cytokines in nor-
mal brain development due to the presence of these factors
from the first trimester. Animal studies have also demonstrated
that cytokines are present in the fetal brain from early gesta-
tion (Meyer et al., 2006b, 2009) and have correlated increases
in specific cytokines, such as TNF-α and IL-1β, with impor-
tant development events in the brain (Dziegielewska et al.,
2000). In terms of the human, the role of cytokines in nor-
mal brain development requires further research, particularly
as this may be somewhat different between species. Differences
may also exist in the function of specific cytokines in the pre-
natal and postnatal brain. For example, the cytokine IL-1β, is
highly expressed in the fetal brain of rat and is thought to be an
important astroglial growth factor during development (Giulian
et al., 1988), but is expressed at a low level in the adult brain,
although rapidly up-regulated as a host defence response to injury
(Rothwell and Luheshi, 2000).
In the adult brain, cytokine expression occurs mostly in
glia, predominantly microglia and astrocytes (Meeuwsen et al.,
2003; Jack et al., 2005). A similar association has been found
in the fetal brain, with studies in vitro having shown that
cytokines and chemokines can be produced by human fetal
microglia and astrocytes (Giulian et al., 1988; Hua and Lee,
2000; Lee et al., 2002; Rezaie et al., 2002a) and that cytokine
production is increased by these glial cells in response to stim-
ulation by a viral infection (Cheeran et al., 2001; Lokensgard
et al., 2001). Similar to the adult brain, glial cells in fetal
brain are also thought to receive and respond to signals
from inflammatory cytokines (Hanisch, 2002). Furthermore,
cytokines are thought to be critically important in glial cell
development, in addition to neural and synaptic maturation
(Deverman and Patterson, 2009).
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WHAT IS THE SOURCE OF THE CYTOKINES THAT INDUCE
FETAL BRAIN INJURY?
Many theories have been put forward to suggest how an infec-
tion during pregnancy could alter fetal brain development, and
it is likely that cytokines play a major role. It is known that
the activation of the maternal immune system by an infection
during pregnancy induces the release of inflammatory cytokines
(Shobokshi and Shaarawy, 2002; Zheng et al., 2012), but how
these cytokines enter the fetal circulation and alter fetal brain
development remains unclear.
Human and animals studies into the human influenza virus
have shown that the virus or antibodies produced in response
to the virus do not cross the placenta (Irving et al., 2000) and
are not found in the brains of offspring where the mother had
been exposed to influenza (Shi et al., 2005; Short et al., 2010;
Fatemi et al., 2012). However, animal studies have shown that the
activation of the maternal immune system by infections, such as
influenza, alters cytokine levels in the placenta, amniotic fluid and
fetal brain (Urakubo et al., 2001; Gilmore et al., 2005; Ashdown
et al., 2006; Meyer et al., 2006b). These studies support the idea
that it is not the virus that directly infects the fetal brain, but a
substance released in either the maternal or placenta compart-
ments that enters the fetal compartment and alters fetal brain
development.
Studies have provided evidence that an increase in levels of
cytokines in the maternal circulation could enter the fetal cir-
culation, via the placenta, to influence fetal development. For
example significant levels of cytokines were present in amni-
otic fluid and fetal tissues after the administration of spe-
cific cytokines, such as IL-2 and IL-6, to pregnant rodents
(Dahlgren et al., 2006; Ponzio et al., 2007), indicating that
these cytokines are able cross the placenta and enter the fetal
circulation. In addition, the pro-inflammatory cytokine IL-6
was found to be capable of bi-directional transfer in a healthy
term human placenta, although the same study also found
that other cytokines including IL-1α and TNF-α show mini-
mal transfer through the placenta and into the fetal circulation
(Zaretsky et al., 2004).
As it still remains unclear how readily other cytokines and
chemokines cross the placenta, the production of cytokines from
the placenta itself is a second possibility to explain the presence
of these substances in the amniotic fluid and fetal circulation. In
vitro studies have shown that human trophoblast cells, from as
early as the first trimester, respond to a viral mimetic that acti-
vates TLR-3 (Abrahams et al., 2006). As a result, type 1 interferons
(IFN), inflammatory cytokines and other immunological media-
tors are inducted that may then enter both the fetal and maternal
circulations.
Cytokines can be grouped according to their functions in
the either inducing or suppressing inflammation. For example,
IL-1β, IL-6, and TNF-α can be regarded as pro-inflammatory
cytokines due to their role in early host defence against infec-
tion or disease, and in the development and progression of
inflammation (Dinarello, 2000). Whereas cytokines such as IL-
10 and transforming growth factor (TGF)-β can be considered as
anti-inflammatory cytokines that have primarily immunomod-
ulatory functions by limiting excess inflammatory reactions
(Opal and DePalo, 2000). Researchers have hypothesized that
it may not be the increased production and release of spe-
cific cytokines into the fetal compartment but instead a shift
in excess pro- or anti-inflammatory cytokines during an infec-
tious response, that may be the critical feature in disrupt-
ing normal brain development (Meyer et al., 2009; Patterson,
2009). For example, the over-expression of either the pro-
inflammatory cytokine, IL-6 (Smith et al., 2007) or the anti-
inflammatory cytokine, IL-10 (Meyer et al., 2008a) in pregnant
rodents, causes similar cognitive and behavioral abnormalities
in the offspring. As a consequence, it has been suggested that
postnatal abnormalities would not arise if there were similar
changes in both classes of cytokines, which therefore did not
alter the balance between pro- and anti-inflammatory cytokines
during fetal development (Meyer et al., 2009; Meyer, 2011).
Although when a viral mimetic was administered to an IL-
6 knockout mouse model or when co-administered with an
IL-6 blocking antibody during pregnancy, the viral mimetic is
no longer capable of producing the behavioral abnormalities
and transcriptional changes in the offspring seen prior to IL-
6 intervention (Smith et al., 2007). Instead this study suggests
that the specificity of the cytokine response plays a key role
in mediating the effects of a prenatal infection on the fetal
brain.
Whether specific cytokines are derived in either the maternal
or fetal system, or there is a change in the balance of cytokines, the
stage of development of the fetal brain and/or immune system is
an obvious factor in determining the consequences of a maternal
infection. Epidemiological studies investigating various prenatal
infections found that the risk of developing mental illness disor-
ders can be dependent on the timing of exposure to an infection
(Brown et al., 2000b, 2004a). In addition, studies investigating the
administration of the viral mimetic, (Poly I:C) during gestation
have provided further evidence that the time of prenatal exposure
critically determines the patterns of behavioral and neurological
abnormalities displayed in the offspring (Meyer et al., 2006a,b,
2008b). These studies found alterations in latent inhibition
(Meyer et al., 2006a), exploratory activity (Meyer et al., 2006b)
and sensorimotor gating (Meyer et al., 2008b), as well as deficits
in an important neurodevelopmental market, Reelin expression
(Meyer et al., 2006b) in the brain of offspring exposed to Poly I:C
in early to mid gestation. Reversal learning deficits (Meyer et al.,
2006b), impairments in spatial working memory (Meyer et al.,
2008b) and increased apoptosis (Meyer et al., 2006b) were only
demonstrated in mid-late prenatally exposed offspring. Cytokine
levels in thematernal circulation and fetal brain also alter depend-
ing on the timing of Poly I:C administration, with greater levels
of IL-10 and TNF-α when administered at early-mid compared
to late gestation (Meyer et al., 2006a). These studies demonstrate
that an immunological challenge at different times of prenatal
development may have important, different neurodevelopmental
consequences.
We propose two mechanisms by which an induction or
a change in inflammatory cytokines during fetal life can
have long term consequences on development; The effects of
cytokines on 1) glial cells and 2) the hypothalamic-pituitary-
adrenal axis.
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THE EFFECT OF CYTOKINES ON GLIAL CELLS
The suggestion that an increase of particular cytokines or a change
in the critical balance between classes of cytokines caused by
a prenatal infection may detrimentally alter normal fetal brain
development, also assumes that glial cells are likely to be involved
or at least affected as these cells are shown to not only produce
cytokines but respond to them in the fetal brain (Hanisch, 2002).
Glial cells, such as astrocytes and microglia, are essential
for normal brain development. Astrocytes are critical for the
development of neurons and synapse formation during brain
development and support neuronal repair and synapse forma-
tion (Benveniste, 1998; Ullian et al., 2004). In addition, astrocytes
contribute to central nervous system homeostasis by supporting
neuronal repair, contributing to the metabolism of neurotrans-
mitters and regulating metabolite levels (Dong and Benveniste,
2001). For example, astrocytes are the major cell in the brain
that produces kynurenic acid and quinolinic acid, N-methyl-D-
aspartate (NMDA)-receptor antagonist and agonist, respectively,
that modulate excitatory glutamatergic synapses. Therefore, an
increase in astrogliosis also alters kynurenic metabolism, leading
to changes in NMDA receptor activity (Schwarcz et al., 2012).
Changes in the concentrations of these metabolites are associ-
ated with neurodegenerative and psychiatric diseases (Schwarcz
et al., 2012), and it is now known that alteration of kynurenic
acid synthesis during pregnancy in rats results in abnormal
behavioral outcomes postnatally (Alexander et al., 2013; Forrest
et al., 2013). In addition, the enzymatic activity of indoleamine
2,3-dioxygenase (IDO), which can be enhanced or inhibited by
pro- or anti- inflammatory cytokines, respectively, can change the
activation of the previously described kynurenic pathway (Myint
et al., 2012).
Microglia are the resident immune cells of the central nervous
system, and not only play a role in phagocytosis (Tremblay et al.,
2011) but also produce cytokines and chemokines (Deverman
and Patterson, 2009). In the adult brain resting microglia are
thought to have a ramified morphology, with long branching
processes that may be sensitive to (i.e., they “monitor”) the chem-
ical composition of the cellular environment and identify the
presence of injured cells and toxins associated with infection
(Rezaie andMale, 1999).More recently researchers have suggested
that “resting” microglia in the postnatal brain are dynamic in
nature, continually extending and retracting these branching pro-
cess (Nimmerjahn et al., 2005; Tremblay et al., 2011). In either
case, ramified (or resting) microglia react to insult or injury by
transforming into amoeboid microglia where the ramified pro-
cesses are withdrawn and the central cell body region becomes
enlarged (Bilbo and Schwarz, 2009; Deverman and Patterson,
2009). Amoeboid or activated microglia are actively phagocytic,
and synthesize large amounts of inflammatory cytokines such
as IL-1β, IL-6 and tumor necrosis factor (TNF)-α (reviewed in
Bilbo and Schwarz, 2009). More recent studies (Rezaie et al.,
2002b; Monier et al., 2007), utilizing technological advances in
microscopy, have provided further confirmation of earlier find-
ings (Kershman, 1939), that in contrast to the adult brain, fetal
microglia display an amoeboid appearance when first present and
progressively ramify during development.
As glial cells play an important role in normal brain devel-
opment, it has been suggested that an activation or change
in these cells, may alter the function of these cells and have
a detrimental impact on the fetal brain (Perry et al., 2010).
After exposure to a prenatal infection/inflammation, the pre-
dominantly amoeboid microglia in the fetal brain can potentially
remain in this state into postnatal life (Bilbo and Schwarz, 2009;
Hagberg et al., 2012), possibly exposing the fetal and post-
natal brain to over-expression of pro-inflammatory cytokines,
such as IL-1β, IL-6 and TNF-α [reviewed in Jonakait (1997);
Bilbo and Schwarz (2009)].
As further evidence of the cytokine-glial hypothesis, alter-
ations in structure and function of astrocytes and microglia have
been identified in post-mortem studies of the brains of mental
illness patients. Astrogliosis has been reported in human brain
studies of autistic patients (Laurence and Fatemi, 2005). For
schizophrenia this association is less clear, with different studies
showing decreased (Webster et al., 2005), unchanged (Falkai et al.,
1999) or increased (Arnold et al., 1996) levels of astrocytes in the
brains of schizophrenic patients. Increasedmicroglial cell number
(Steiner et al., 2008), microglial activation (Bayer et al., 1999), and
microglial cell density (Radewicz et al., 2000) in the post-mortem
brains of schizophrenic patients are more consistent findings, as
also for autistic patients (Morgan et al., 2010). The localization
of activated (amoeboid) microglia has also been shown to be dif-
ferent in the prefrontal cortex, anterior cingulate cortex and hip-
pocampal brain regions of schizophrenic patients (Steiner et al.,
2006). As previously outlined, amoeboid or activated microglia
produce large amounts of inflammatory cytokines including IL-
1β, IL-6 and TNF-α [reviewed in Jonakait (1997); Bilbo and
Schwarz (2009)]. Therefore, it is thought that the “priming” of
microglia can cause an exaggerated cytokine response by these
cells to a subsequent insult, compared to “unprimed” microglia
(Czeh et al., 2011; Hagberg et al., 2012), thus exacerbating brain
injury.
More recently, animal studies by us and others using prenatal
immune activation, to cause behavioral neuropathologies compa-
rable to mental illnesses encountered in the human population,
have provided further evidence for the importance of microglial
activation in pathogenesis of mental disorders such as schizophre-
nia. Microglial activation was found in brains of adult offspring
following treatment of the mother with lipopolysaccharide dur-
ing pregnancy (Borrell et al., 2002), and also in the brains of
offspring following prenatal exposure to Poly I:C (Graciarena
et al., 2010; Juckel et al., 2011; Ratnayake et al., 2012; Giovanoli
et al., 2013). In such studies, conducted in pregnant rats and
mice, the fetal brain is very immature at the time the infection
raises an immune challenge and induces the cytokine changes
described above. But even in a more precocial species such as the
spiny mouse, where brain development is much more advanced
by the time of birth, a very low dose (0.5mg/kg) of prenatal Poly
I:C treatment also increased microglial activation in the neonatal
hippocampus (Figure 2) and led to persistent behavioral impair-
ments in juvenile offspring (Ratnayake et al., 2012), confirming
that prenatal subclinical infection has profound effects on brain
development.
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THE EFFECTS OF CYTOKINES ON THE
HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
The immune system and the hypothalamic-pituitary-adrenal
(HPA) axis, responsible for generalized stress responses, are inex-
tricably linked (Franchimont et al., 2002; Chrousos and Kino,
2005; Silverman et al., 2005; Gibb et al., 2011). Cytokines can
potently activate the HPA axis, to increase adrenocorticotropic
hormone (ACTH), corticotropin-releasing hormone (CRH),
arginine vasopressin and corticosterone levels (Besedovsky et al.,
1986; Muller et al., 1999; Dunn, 2000; Schmidt et al., 2003).
Therefore, cytokines, that have entered the fetal circulation due
to a maternal infection, can potentially stimulate the release of
CRH and arginine vasopressin from the fetal hypothalamus. The
cytokine-elicited release of these hormones, shown in Figure 1,
in turn, stimulates the secretion of ACTH from the anterior pitu-
itary gland, and thus glucocorticoids from the adrenal cortex. In
turn, glucocorticoids inhibit the induction of pro-inflammatory
cytokines while stimulating the production of anti-inflammatory
cytokines (Chrousos and Kino, 2005).
Although glucocorticoids are essential for normal brain devel-
opment, exposure of the fetal brain to excess glucocorticoids
can also modify fetal brain development and permanently alter
the function of the HPA axis in postnatal life (Matthews, 2000;
Welberg and Seckl, 2001; Seckl, 2004; Kapoor et al., 2006).
FIGURE 1 | The relationship between cytokines and
hypothalamic-pituitary-adrenal (HPA) axis. Cytokines, produced in
response to an infection, can stimulate the release of
corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) from
the hypothalamus. These hormones stimulate the secretion of
adrenocorticotrophic hormone (ACTH) from the anterior pituitary gland, and,
in turn, the secretion of glucocorticoids (GC) from the adrenal cortex.
During fetal life, excess GC can change the long-term function of the
HPA-axis and if exposed to the fetal brain, GC can also modify brain
development. In addition, GC can inhibit the induction of pro-inflammatory
cytokines while stimulating the production of anti-inflammatory cytokines, a
process that can also act to change the function of HPA-axis.
Pro-inflammatory cytokines, such as IL-1, IL-6 and TNF-α, can
alter the actions of glucocorticoids by interfering with their
intracellular signaling system (Dunn, 2000; Bornstein et al., 2004;
Giovanoli et al., 2013). The use of specific cytokine or glucocor-
ticoid receptor knock-out mice in future studies could further
help distinguish the role of each of these molecules during pre-
natal infection, and may reveal the link between infection and the
neuroendocrine system that affects brain development.
The involvement of the HPA axis on cytokine changes
in the fetal brain is dependent on the ability of the fetus
to produce an appropriate stress response involving the HPA
axis, and therefore, the time of the infection during preg-
nancy can be expected to modify the impact on the fetal
brain development. Particularly as HPA axis development is
strongly linked to the development of specific regions of the
brain (Matthews, 2002). Hormones produced by the HPA axis
can be detected early in development, by 12 weeks of ges-
tation (Ng, 2000). The hormones, such as CRH and ACTH,
have important actions during fetal development on the regula-
tion of the HPA axis and the subsequent secretion of adrenal-
derived glucocorticoids. Appropriate levels of glucocorticoids,
such as cortisol and DHEA, are essential in maintaining intrauter-
ine homeostasis and neuroprotective mechanisms, where as
excessive levels of these hormones can be deleterious to fetal
development.
FIGURE 2 | Number of Iba1 immunopositive cell bodies (A) and
percentage Iba1 staining in the hippocampus in PBS (solid bars) and
Poly I:C (dashed bars) prenatally exposed animals at 1d (white bars)
and 100d (gray bars) postnatal age. Iba1 immunopositive staining in the
hippocampus from animals prenatally exposed to PBS (C) and Poly I: (D) at
1d postnatal age. Note an increased number Iba1 immunopositive cell
bodies in the Poly I:C (A,D) neonatal brains compared to the PBS (C).
Although, note an increase in the percentage of Iba1 staining in PBS
neonatal brains (B,C) compared to Poly I:C (D). The combination of these
two findings, of more microglial cell bodies and fewer branching processes,
make it possible to conclude that there are more activated, and fewer
ramified, microglia in the neonatal hippocampus of animals born to mothers
administered with the viral mimetic, Poly I:C. The data are shown as means
± SEM in all graphs. ∗ refers p < 0.05. Scale bar = 100μM in (C,D).
Adapted from Ratnayake et al. (2012).
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It is well known that changes during fetal development can
permanently programme the HPA axis, to have a long lasting
impact on neuroendocrine function in postnatal life [reviewed in
Matthews (2002); Bale et al. (2010); Howerton and Bale (2012)].
As it is not within the scope of this article to extensively review
this concept, briefly, previous studies have demonstrated that
adult animals exposed to a prenatal stressor, show DNA methyla-
tion and expression changes in glucocorticoid receptor and CRH
(Nemeroff, 1992; Kapoor et al., 2008; Mueller and Bale, 2008).
DNA modification by methylation can alter long term gene func-
tion, for example by silencing gene expression, without altering
sequence variation. Therefore, it possible that a prenatal stress
response, caused by exposure to an infection or inflammatory
event, may result in the long lasting, epigenetic reprogramming
of genes involved in HPA axis function.
CONCLUSION
While mental illnesses such as schizophrenia and autism have
been associated with prenatal infection, the variety of infec-
tions producing similar outcomes suggest that a response by the
immune system common to all infections may be the important
factor in the etiology of mental illness disorders. The common
pathway may include induction of cytokines, triggered by activa-
tion of TLRs to assist in the resolution of disease but which then
produce a pro-inflammatory environment that has downstream
effects that are detrimental to fetal brain development. It is not
entirely clear if significant amounts of cytokines enter the fetal cir-
culation by placental transfer, or if placental and fetal production
of cytokines is also important. However, the evidence is con-
vincing that cytokines produced in response to infection during
pregnancy have detrimental and long-lasting effects on the brain.
Inflammatory cytokines can affect the function of glia in
the developing brain. Early deregulation of glial cells, such as
microglia, may set in motion a cascade of events that lead to per-
manent alterations in these cells. There is substantial evidence for
microglial activation in the post-mortem brains of patients that
suffered a mental illness (Bayer et al., 1999; Radewicz et al., 2000;
Steiner et al., 2006, 2008; Morgan et al., 2010), as well as in ani-
mal models of prenatal infection (Borrell et al., 2002; Graciarena
et al., 2010; Juckel et al., 2011; Ratnayake et al., 2012), suggest-
ing that permanently primed or “sensitized” microglia may be an
important cellular component of the neuropathology of mental
disorders that arise after birth. Another action of cytokines that
may have long-term consequences is their ability to elicit a stress
response via the activation of fetal HPA, which can subsequently
cause long-term changes in HPA axis function in postnatal life.
It is possible to conclude that exposure to prenatal infection via
the actions of cytokines can predispose or increase the suscepti-
bility of an individual to future inflammatory events or postnatal
stressors, as the function of the systems that act to resolve these
insults have been permanently altered. Therefore, we believe it
is important for future research to investigate two-hit models of
mental illness disorders i.e., a first hit during fetal life—a prena-
tal viral or bacterial infection that drives an early susceptibility
to mental illness via the activation of inflammatory pathways,
such as the persistent activation of microglia, or changes in HPA
axis function- in combination with a second hit during postna-
tal life—an immune activator or environmental factors such as
chronic stressors or trauma. The development of these models
may provide a unique period of time, prior to the “second hit,”
to develop and target potential interventions or treatments to
prevent the “full-blown” onset of a mental illness disorder.
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